3.85%C 7.22 11.94%GE 17.61 13.61%
The Global Business News Leader | Tuesday, 2 Dec 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- INVESTING
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
PDL BIOPHARMA INC.
PDLI (NASDAQ)
$ 9.34 
Change: +0.36 +3.85% | Volume: 1,894,369
Change: +0.36 +3.85% | Volume: 1,894,369
Sponsored by 
PDL BIOPHARMA - Fundamental Profile
Company Information
| Ticker Symbol: | PDLI |
|---|---|
| Exchange: | NASD |
| Contact Info: | 1400 Seaport Boulevard Redwood City CA 94063 650 454-1000 |
| CEO/President: | Mark McDade |
| Industry: | Medical - Biomedical / Standard Industry Code: 2836 |
| Description: | Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. |
Share Information
| Shares Outstanding: | 119,420 (000) | Market Value: | 1,144,060 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 95.47% | Number of Inst.Shareholders: | 2.60% |
| Last Quarter Sales: | 77.35 ($Mil.) | Last Quarter Net Income: | 55.69 ($Mil.) |
| Last Quarter EPS: | 0.08 | P/E Ratio: | 27 |
| Most Recent Earnings: | 0.08 on 11/06/08 | Earnings Per Share: | 0.05 |
| Most Recent Split: | 2-1 on 10/10/01 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | 4.250 on 05/06/08 | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Top Competitors
| AMGEN INC. |  |
+5.60 | 55.54 |
| GILEAD SCIENCES |  |
-9.90 | 44.79 |
| CELGENE CORPORA | |
-21.80 | 52.10 |
| STEMCELLS INC. | |
-52.80 | 1.06 |
| GENENTECH INC | |
-3.20 | 76.60 |
Partners   
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives